secwatch.observer — SEC 8-K summary
======================================

Issuer:     Canopy Growth Corp (CGC)
CIK:        0001737927
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0000950170-24-123682
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Canopy Growth Q2 revenue down 9% to $63M; adjusted EBITDA loss improves 54% to $5.5M
--------------------------------------------------------------------------------

- Net revenue $63.0M, down 9% YoY; excluding divested businesses, up 3%.
- Adjusted EBITDA loss $5.5M, improved 54% YoY; net loss from cont. ops $131.6M.
- Canada medical revenue +16% YoY; Storz & Bickel +32% on Germany reform and US sales.
- Early prepayment reduced secured term loan by US$100M; cash balance $231M.
- Canopy USA closed Wana acquisition post-quarter; Acreage acquisition on track for H1 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737927/000095017024123682/0000950170-24-123682-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737927/000095017024123682/cgc-20241108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-123682

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer